Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 2010

View Archived Issues

MicroRNA expression profiles associated with malignancy potential of pancreatic cystic tumors

Phase I and II data reported on blinatumomab in hematological cancers

Intratumoral TG-4023 gene therapy is feasible in patients with liver cancer

Aliskiren/amlodipine combination effective in hypertension

UDPGT 1-4 gene polymorphism affects lamotrigine pharmacokinetics

Evatanepag accelerates fracture healing in phase II trial

TRUST trial further explores efficacy and safety of corifollitropin alfa

New apoptosis-inducing agents discovered at Brock University

Nycomed presents new chemokine CCR3 receptor modulators

Roche claims new JNK inhibitors with anti-inflammatory potential

New cannabinoid CB2 receptor ligands in development at Abbott

Infinity and Intellikine to codevelop INK-1197 and other PI3K inhibitors

FDA approves Beech Tree Labs' IND for BTL-TML-HSV

Achillion patents novel compounds to treat hepatitis C

Winston Labs submits NDA for Civanex for osteoarthritis signs in the U.S.

Nile Therapeutics doses last patient in phase II trial of CD-NP in ADHF

FDA approves Atir IND in patients with mismatched bone marrow transplant

E.C. approves Reyataz capsules for HIV-1 in pediatric patients

Fornix completes sale of allergy division to ALK-Abello

Oramed and sanofi-aventis enter agreement for oral insulin capsules

Stem cell-based therapy in development for corneal vision impairment

Preclinical data reported for intravenous Restanza for hospital use

Neoprobe begins third phase III trial of Lymphoseek

AVI BioPharma applies for IND for AVI-4658 in DMD

Cellceutix completes animal safety pharmacology studies required by FDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...